Shankar Lal Rampal Dye-Chem LimitedSRDCorporate

Trading - Chemicals Latest results: Mar 2025 1 quarters of data
₹38.76
MCap ₹248 Cr
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹107 Cr
Sales · Mar 2025
₹4 Cr
Operating Profit · Mar 2025
3.6%
OPM % · Mar 2025
₹3 Cr
Net Profit · Mar 2025
₹0.39
EPS · Mar 2025

📝 Shankar Lal Rampal Dye-Chem Limited — results explained

Quarter ended March 2025 (Q4 FY25)

Shankar Lal Rampal Dye-Chem Limited reported revenue of ₹107 crore for the quarter ended March 2025 (Q4 FY25).

Net profit stood at ₹3 crore. Earnings per share (EPS) came in at ₹0.39.

Operating profit stood at ₹4 crore — an operating margin (OPM) of 3.6%.

Valuation snapshot

At the current price of ₹38.76, SRD has a market capitalisation of ₹248 crore.

Within the Trading - Chemicals industry, it is the 5th-largest of the 10 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 73.61%, foreign institutional investors (FIIs) 0.04%, public shareholders 26.36% of Shankar Lal Rampal Dye-Chem Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹248 Cr
Current Price ?
₹38.8
P/E ?
N/A
Industry P/E ?
27.10
P/B ?
2.02
P/S ?
N/A
P/FCF ?
-35.42
Enterprise Value ?
₹273 Cr
EV/EBITDA ?
N/A
PEG ?
N/A
Earnings Yield ?
N/A
Dividend Yield ?
N/A
Profitability & Returns
Sales (TTM) ?
N/A
OPM ?
N/A
Profit after tax (TTM) ?
N/A
EPS (TTM) ?
N/A
ROCE ?
14.0%
ROE ?
N/A
ROA ?
N/A
Growth
Sales — latest qtr ?
₹107 Cr
PAT — latest qtr ?
₹3 Cr
YoY qtr sales growth ?
N/A
YoY qtr profit growth ?
N/A
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹25 Cr
Debt to Equity ?
0.20
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
73.61%
Change in promoter holding ?
0.01%
Pledged percentage ?
N/A
Market
Return 3 months ?
0.2%
Return 6 months ?
-12.0%

🗓️ Quarterly results (1 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2025 YoY % QoQ %
Sales 107 — —
Operating Profit 4 — —
Other Income — — —
Interest 0 — —
Depreciation 0 — —
Profit Before Tax 4 — —
Net Profit 3 — —
EPS 0.39 — —
OPM % 3.6% — —

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 64646464 +0.0%
Reserves 28354659 +28.3%
Borrowings 1661825 +38.9%
Other Liabilities 2118 +700.0%
Total Liabilities 110106129157 +21.7%
Fixed Assets 1111 +0.0%
CWIP 0000 —
Investments 0000 —
Other Assets 109104128155 +21.1%
Total Assets 110106129157 +21.7%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 156-13-7 +46.2%
Cash from Investing Activity -0-00-0 —
Cash from Financing Activity -6-11106 -40.0%
Net Cash Flow 8-5-2-1 +50.0%
Free Cash Flow 146-13-7 +46.2%
CFO/OP 91%88%-52%-14% +73.1%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 75736980 +15.9%
Inventory Days 13131212 +0.0%
Days Payable 2115 +400.0%
Cash Conversion Cycle 86858087 +8.8%
Working Capital Days 941199795 -2.1%
ROCE % 22%9%14%14% +0.0%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 73.60%73.60%73.60%73.60%73.61% +0.0%
FIIs 0.21%0.41%0.15%0.04%0.04% +0.0%
Public 26.18%25.97%26.25%26.36%26.36% +0.0%
No. of Shareholders 15,13514,84814,28613,94413,797 -1.1%

⚖️ Peer comparison

Industry: Trading - Chemicals · 10 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 UNIENTER Uniphos Enterprises ₹87.30 1,214 30.0 26 20 -15.6% 77.5% -71.3% 7542.1% -100.0% -60.8%
2 VINYLINDIA Vinyl Chemicals ₹224.97 413 22.1 601 19 2.0% 3.1% 4.3% -26.1% -34.1% 48.8%
3 524444 Evexia Lifecare ₹2.91 374 — 119 2 1.7% 1.6% 17.8% 28.6% 39.8% -33.4%
4 542012 A-1 ₹343.95 288 n/m 453 9 3.6% 1.9% 3.2% 64.1% 170.5% 427.4%
5 SRD Shankar Lal ₹37.24 238 12.9 478 18 5.4% 3.9% 15.7% 18.4% 10.9% 116.8%
6 506734 Mysore Petro ₹165.80 85 10.1 56 11 -15.6% 19.1% 41.6% -64.6% 57.5% 2490.2%
7 539939 Yash Chemex ₹54.42 53 28.3 131 3 0.2% 2.0% 51.2% -12.7% -42.9% 21.1%
8 524522 Laffans Petrochemicals ₹41.02 24 — 6 -1 -45.1% -18.1% -39.5% -79.5% 261.3% -22.6%
9 539800 CHD Chemicals ₹6.49 6 — 6 -0 -4.4% -4.3% -23.8% -42.1% 27.9% 18.2%
10 543798 Patron Exim ₹8.35 4 — 24 -1 -4.8% -4.5% — — -98.0% -443.8%
❓ Frequently asked questions
What was Shankar Lal Rampal Dye-Chem Limited's revenue in Q4 FY25?
Shankar Lal Rampal Dye-Chem Limited reported revenue of ₹107 crore for the quarter ended March 2025 (Q4 FY25).
What was Shankar Lal Rampal Dye-Chem Limited's net profit in Q4 FY25?
Net profit stood at ₹3 crore. Earnings per share (EPS) came in at ₹0.39.
What is SRD's market capitalisation and P/E ratio?
At the current price of ₹38.76, SRD has a market capitalisation of ₹248 crore.
Who owns Shankar Lal Rampal Dye-Chem Limited? (shareholding pattern)
As of Jun 2026, promoters held 73.61%, foreign institutional investors (FIIs) 0.04%, public shareholders 26.36% of Shankar Lal Rampal Dye-Chem Limited.
TTM ends N/A. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI